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WHAT THIS PAPER ADDS
 This study describes towhat extent and onwhich criteria (Dutch) vascular surgeons decide to refer patients with peripheral arterial
occlusive disease for supervised exercise therapy. Arguments not to refer for supervised exercise therapy seem to be outdated;
therefore, this study may inﬂuence clinical practice. This study showed that supervised exercise therapy, including lifestyle
coaching, should have more emphasis in the current management of intermittent claudication and possibly critical limb ischaemia.a r t i c l e i n f o
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Objectives: Although international guidelines state that supervised exercise therapy (SET) should be
offered to all patients with intermittent claudication (IC), SET appears to be underutilised in clinical
practice. The aim of this study was to document current opinions of Dutch vascular surgeons on SET as
treatment option for peripheral arterial occlusive disease (PAOD).
Materials and methods: Vascular surgeons and fellows in vascular surgery were asked to complete a 24-
question survey either at the 2011 Annual Meeting of the Dutch Society for Vascular Surgery or online.
Results: Ninety-one participants, including 83 vascular surgeons (51% of all Dutch vascular surgeons),
completed the survey. The respondents would refer 75.4% of newly diagnosed patients with IC for SET.
SET was considered less useful in patients with IC and major (cardiopulmonary) co-morbidity or
a signiﬁcant iliac artery stenosis. In critical limb ischaemia, the combination of SET and angioplasty was
considered useful in 71.9%. Respondents regarded patient satisfaction (63.3%) and improvement in pain-
free or maximal walking ability (26.6%) as clinically most relevant goals of SET. Most (84.4%) agreed that
SET should also include lifestyle management.
Conclusion: Although the vast majority of Dutch vascular surgeons consider SET as an important treat-
ment option for PAOD, SET should receive more emphasis in clinical practice since arguments not to refer
for SET are outdated. Furthermore, vascular surgeons agree that lifestyle management should be inte-
grated in SET.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.f Vascular Surgery, Catharina
erlands. Tel.: þ31 402398764;
ciety for Vascular Surgery. PublisheIntroduction
In the management of intermittent claudication (IC), supervised
exercise therapy (SET) leads to superior results (walking distances
and quality of life) compared to a single walking advice.1,2 When
compared to angioplasty, patients with IC beneﬁted equally from
either angioplasty or hospital-based SET after a 12-month follow-d by Elsevier Ltd. All rights reserved.
Table 1
Baseline characteristics.
Number of Responses (%)
Total respondents 91 (100)
Gender
Men 78 (85.7)
Women 13 (14.3)
Age
30e40 23 (25.3)
40e50 40 (44.0)
50e60 20 (20.9)
60þ 9 (9.9)
Professional career
Fellow in vascular surgery 8 (8.8)
Vascular surgeon 83 (91.2)
Professor in vascular surgery 3 (3.3)
Hospital setting
Academic hospital 15 (16.5)
Non-academic hospital 76 (83.5)
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reason, initial management of IC should consist of cardiovascular
risk management and SET, as clearly stated in contemporary
international guidelines.5,6
Community-based SET seems as efﬁcacious as hospital-based
SET, is cost-effective and should therefore be available for all
patients with IC.7,8 Nonetheless, in clinical practice, SET seems
underutilised because of limited availability of physical or exercise
therapists with speciﬁc knowledge on peripheral arterial occlusive
disease (PAOD) and/or an SET treatment protocol. For this reason,
Nicolaï et al. extensively trained all participating community-based
physical therapists before they were allowed to participate in the
multicentre randomised controlled ExitPAD (EXercIse Therapy in
patients with Peripheral Arterial Disease) trial.2 Another explana-
tion for the underutilisation of SET could be the differing views on
the indications for SET, such as concomitant signiﬁcant cardiopul-
monary comorbidity, patient’s age, aortic or iliac artery obstruction
as cause of IC or SET in combination with revascularisation for
critical limb ischaemia (CLI). Furthermore, in severe or invalidating
cases of IC vascular surgeons often perform a vascular intervention.
However, a solid deﬁnition of ‘severely disabling’ or ‘invalidating’ IC
is lacking.
The aim of this study is to document current opinions of
vascular surgeons and fellows in vascular surgery on SET as treat-
ment option for PAOD. We speciﬁcally wanted to ﬁnd out to what
extent and on which criteria Dutch vascular surgeons decide to
offer or deny SET to patients with PAOD.
Materials and Methods
In spring 2011, Dutch vascular surgeons and fellows in
vascular surgery were asked to complete a 25-question survey
regarding SET as treatment option for PAOD. Participants could
complete the survey either on the Annual Meeting of the Dutch
Society for Vascular Surgery or on a secure online website. Most
questions (21/25) were deﬁned as statements that participants
could agree or disagree with. One question was a multiple
answer question, and three were open-ended questions
(regarding the number of SET referrals per hospital, percentage
of all patients with IC referred and criteria for successful
conservative therapy).
Data extraction
Data extraction was performed by two independent investi-
gators (GL and HvD). All surveys were analysed for missing
answers and the number of responses per question were noted. If
answers were unclear, the same investigators determined if the
answer could be classiﬁed to a speciﬁc category. If this was not
possible or in case of disagreement between the two investigators
the answer was excluded from analysis. For the open-ended
question ‘when is conservative therapy considered successful’,
answers were classiﬁed by each of the two investigators. In case
of disagreement, concurrence was sought by means of discussion.
For the remaining open-ended questions, the numbers and
percentages were extracted. When a range of numbers or
percentages was given, the mean was calculated and used as
deﬁnitive answer.
Statistical analysis
Data were analysed for both descriptive and analytical statistics.
Because of a skewed distribution of continuous variables (referral
data), evaluated by a one-sample KolmogoroveSmirnov test, we
performed a ManneWhitney U test to determine statisticaldifference between two groups. Medians and interquartile ranges
(IQRs) were calculated to describe the spread of data. A p-value
<0.05 was considered to indicate statistical signiﬁcance. All anal-
yses were performed using IBM SPSS Statistics Version 19 (SPSS
Inc., Chicago, IL, USA).Results
Participants
In total, 91 participants, including 83 vascular surgeons,
completed the survey. This comprises 51% of all Dutch vascular
surgeons and seems therefore representative as nationwide survey.
All respondents are further classiﬁed by gender, age group,
professional career and hospital setting (Table 1).Referral information
The number of new patients with IC, treated annually, was
estimated to be 476 per hospital (median 400, IQR 260e640). No
signiﬁcant (p ¼ 0.626) difference was found between academic and
non-academic hospitals. Overall, 88 respondents estimated to refer
on average 75.4% (median 80%, IQR 66.3e95.0) of their patients
with IC for SET.SET indications
Table 2 lists the attitude towards indications for SET. Most
respondents had a positive attitude towards SET in general.
However, continuation of SET after 3 months of treatment without
functional improvement was only preferred by 60.0% of the
respondents.
Most respondents did not consider a maximum walking
distance of<100m or age older than 80 years a contraindication for
SET. However, in patients with a signiﬁcant iliac artery stenosis
(70.8%), patients with a coinciding chronic pulmonary condition
(e.g., chronic obstructive pulmonary disease (COPD)) (65.9%) or
chronic heart failure (69.8%), SET was less frequently thought to be
useful.
As additional treatment before or after angioplasty for CLI, SET
was thought to be useful by 71.9% of the respondents, while 64.8%
would recommend SET as an adjunct to bypass surgery.
Table 2
Level of agreement to statements regarding the use of SET.
Agreement
% n
SET in general
SET is more effective than a single walking advice 100 (89/89)
In addition to CVRM, SET is the primary treatment for IC 96.7 (88/91)
Community-based SET is as effective as hospital-based SET 93.3 (84/90)
Feedback of the physical therapist contributes to patient management 85.6 (77/89)
Continuation of SET is useful if patients do not improve in the ﬁrst 3 months of treatment 60.0 (54/86)
SET for intermittent claudication is useful in:
- patients with a maximal walking distance of <100 m 84.4 (76/85)
- patients older than 80 years 81.8 (72/81)
- patient who underwent angioplasty 81.1 (73/89)
- intermittent claudication caused by a signiﬁcant iliac stenosis 70.8 (63/83)
- patients with not-decompensated chronic heart failure 69.8 (60/84)
- patients with a chronic pulmonary condition (e.g. COPD) 65.9 (60/87)
SET for critical limb ischaemia is useful in addition to:
- angioplasty 71.9 (64/84)
- peripheral bypass surgery 64.8 (57/86)
SET: supervised exercise therapy; IC: intermittent claudication; CVRM: cardiovascular risk management.
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In total, 91 respondents gave 109 categorised answers to the
open question: when is conservative management (cardiovascular
risk management and SET) for IC considered successful? Patient
satisfaction (63.3% of all answers) and progress in pain-free or
maximal walking ability (26.6% of all answers) were the most
prevalent criteria to determine successful conservative manage-
ment (Table 3).
Invalidating IC
The decision to perform angioplasty for IC is determined by the
interpretation of ‘severely disabling’ or ‘invalidating’ IC. For this
reason, respondents were asked which variables contributed to
the decision to perform angioplasty with a multiple-answer
question. Limitation of daily life (LDL), patient reported walking
ability (WA-P) and walking ability determined in the vascular
laboratory (WA-V) were possible answer options. Respondents
could also mention other factors inﬂuencing their decision to
perform angioplasty. The combination of LDL, WA-P and WA-V
was thought to contribute the most to choosing an angioplasty
(32.2%) followed by LDL alone (23.3%), LDL in combination with
WA-P (20.0%) and LDL in combination with WA-V (12.2%)
(Table 4). Other mentioned responses were anatomic location of
the stenosis/occlusion (n ¼ 3), type of stenosis (n ¼ 2), effect of 3
months of SET (n ¼ 1), cardiopulmonary condition (n ¼ 1) and
patency of the procedure (n ¼ 1). LDL alone or in combination
with WA-P or WA-V was mentioned in 87.8% of all answers
(n ¼ 79/90). Walking ability (WA-P or WA-V) was mentioned in
76.7% of all answers (n ¼ 69/90). Therefore, the patient’s LDLTable 3
When is conservative therapy considered successful in IC?.
% n
Patient satisfaction 63.3 (69/109)
Progress in pain-free or maximal walking ability 26.6 (29/109)
Progress in quality of life 2.8 (3/109)
Increased ankle-brachial index 2.8 (3/109)
No further decline in pain-free or maximal walking ability 1.8 (2/109)
Adjustment of patient’s lifestyle 1.8 (2/109)
ADL recovery 0.9 (1/109)
IC: intermittent claudication; ADL: activities of daily living.seems to be more contributing to the decision to perform an
angioplasty than the patient’s walking ability.Content of SET
Most participants agreed that supervised walking exercise
(100%) and lifestyle interventions (84.4%) should be part of super-
vised exercise rehabilitation. Assessment of medication adherence,
side effects and blood glucose levels was not thought to be
contributing to supervised exercise rehabilitation (Table 5).Discussion
The TASC II Inter-Society Consensus for the Management of
Peripheral Arterial Disease recommends SET as part of the initial
treatment for all patients with PAOD.5 As shown in our study, the
vast majority of Dutch vascular surgeons and fellows in vascular
surgery have a positive attitude towards SET as a treatment option
for IC and even CLI. More than three-quarters of new patients with
IC are estimated to be referred for SET.
Results could be inﬂuenced by responder bias, most likely in
favour of a positive attitude towards SET. Therefore, the found
attitude towards SET may in fact be less positive in real life. In
a study on the use of SET in the UK, a large spread in proportion of
patients referred for SET was found.9 Furthermore, only 24% of
resident surgeons had access to supervised exercise in the UK. In
the Netherlands, community-based physical therapists are readily
available and can provide SET according to the guidelines of the
Royal Dutch Society for Physical Therapy, although not all physical
therapists are adequately schooled.Table 4
Determinants for angioplasty in invalidating IC.
% n
LDL þ WA-P þWA-V 32.2 (29/90)
LDL 23.3 (21/90)
LDL þ WA-P 20.0 (18/90)
LDL þ WA-V 12.2 (11/90)
WA-P þWA-V 5.6 (5/90)
WA-P 5.6 (5/90)
WA-V 1.1 (1/90)
IC: intermittent claudication; LDL: Limitations in Daily Life; WA-P: Patient reported
Walking Ability; WA-V: Vascular Laboratory determined Walking Ability.
Table 5
Supervised exercise rehabilitation should contain.
Agreement
% n
Supervised walking exercise 100 (90/90)
Lifestyle interventions (e.g. smoking cessation, dietary advice) 84.4 (76/90)
Supervised alternative exercise (e.g. cycling, strength training) 62.2 (56/90)
Cardiopulmonary risk assessment 54.4 (49/90)
Assessment of used medication 45.6 (41/90)
Assessment of medication adherence 32.2 (29/90)
Assessment of drug side effects 22.2 (20/90)
Assessment of blood glucose levels (in case of DM type 2) 18.9 (17/90)
DM: diabetes mellitus.
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the infrastructure of the health-care system can also be a reason for
underutilisation of SET. If patients need to pay a signiﬁcant amount
of SET treatments, onemight argue that angioplasty would bemore
attractive from a patient point of view. In the Netherlands, the ﬁrst
12 treatments in 2011 (20 treatments in 2012) are covered by an
additional health-care insurance. The basic health-care insurance
covers all additional SET treatments for IC until 1 year of training.
Since most patients have an additional health-care insurance, SET
does not lead to any additional costs for the patient in the Neth-
erlands. However, in other countries this could surely be one of the
reasons of SET underutilisation.
This study showed that the criteria not to refer for SET are
largely based on existence of major co-morbidity (e.g., pulmonary
and cardiac) or a signiﬁcant iliac stenosis causing IC. Apparently, the
respondents did not consider SET to be successful in these partic-
ular patients. This could be explained by concern of major
complications or the belief that SET is ineffective to improve
walking ability or quality of life in these particular patients.
Nonetheless, COPD has shown to be present in 16% of all
patients with PAOD for which pulmonary rehabilitation (PR) is
strongly indicated to increase physical functioning, reduce hospital
admissions, reduce respiratory symptoms and improve ADL-
activities.10e12 PR consists primarily of supervised aerobic exercise
(e.g., treadmill walking and cycling) in a moderate to severe
intensity. Although treatment regimens of PR are not identical to
SET for IC, a signiﬁcantly improved health-related quality of life and
walking distances were found for PR after 12 months of exercise.13
Coronary artery disease has shown to be present in 46e58% of
all patients with PAOD, of which 22% even had active ischaemia.10,14
For these coronary conditions, requiring hospitalisation or cardiac
revascularisation procedures, cardiac rehabilitation in the form of
a moderate-intensity aerobic exercise training was associated with
a 21e34% decrease in 5-year mortality.15 Likewise for congestive
heart failure, cardiac rehabilitation is also advised with a class Ib
recommendation.16 For these patients, exercise training resulted in
a modest (11%) reduction in the adjusted risk for all-cause
mortality.17
Exercise training also appears to be safe in patients with coro-
nary heart disease. In a systematic review, more than 2 million
exercise hours, performed by 51 000 patients with coronary heart
disease, were analysed.18 In total, 21 cardiac arrests (of which three
fatal) and eight nonfatal myocardial infarctions (MIs) were found,
equivalent to one cardiac arrest per 112 000 exercise hours, one
acute MI per 300 000 exercise hours and one fatality per 800 000
exercise hours. It is questionable whether these rates are higher
than the naturally occurring rates of these events. It is clear that SET
should be offered to patients with coexistence of IC and congestive
HF, chronic pulmonary conditions or coronary conditions, although
patient monitoring and exercise intensity should be adjusted to the
patient’s conditions.In case of a signiﬁcant iliac artery stenosis causing IC, studies
comparing SET to angioplasty are lacking. Currently, in the Neth-
erlands, the multicentre randomised controlled SUPER (SUPER-
vised Exercise Therapy or Endovascular Revascularization for
Intermittent Claudication due to an Iliac Artery obstruction) trial is
enrolling 300 patients to investigate which treatment modality
should be performed: SET and deferred angioplasty (in case of SET
failure) or immediate angioplasty.19 The complementary effects of
SET and angioplasty have been described previously. In the MIMIC
(MIld to Moderate Intermittent Claudication) trial, patients with
femoro-poplitaeal and aorto-iliac arterial disease were randomised
to receive either PTA or no PTA (Percutaneous Transluminal
Angioplasty) against a background of SET and best medical
therapy.20 The maximum walking distance after 24 months of
follow-up was 38% greater in the PTA group for the femoro-pop-
litaeal trial (95%; conﬁdence interval (CI) 1e90)(p ¼ 0.04) and 78%
greater in the PTA group for the aorto-iliac trial (95%; CI 0e216)
(p ¼ 0.05). No beneﬁts were found regarding health-related
quality of life. Although more studies are needed to determine
the effect of SET for this particular group of claudicants, SET seems
to show beneﬁcial effects when combined with a vascular
intervention.
Although there is little evidence yet, SET may also be effective as
adjuvant to a revascularisation procedure in patients with inva-
lidating IC or CLI. Kruidenier et al. performed a randomised
controlled trial (RCT) to investigate the effects of SET after angio-
plasty for patients with all stages of PAOD.21 They found that SET
following angioplasty was more effective in increasing maximum
walking distance than angioplasty alone. Badger et al. evaluated the
efﬁcacy of an exercise programme after arterial bypass surgery for
short-distance IC or CLI.22 SET resulted for this group in an
increased maximum walking distance of 175% compared to 4% for
the group with usual care. Although not all included patients had
CLI, these studies indicate that SET could be a useful adjunct after
angioplasty or bypass surgery. In this study, SET was considered by
71.9% of the respondents in addition to angioplasty and 64.8% in
addition to bypass surgery. Although more evidence is needed, SET
seems to have a role in the treatment of CLI.
One might argue that besides smoking cessation, regaining
physical activity in patients with PAOD is the most important
determinant to reduce major cardiovascular events and mortality.
Healthy individuals engaging in moderate-intensity physical
activity (150 min/wk) had a 14% lower coronary heart disease risk
compared with 20% reduction in those engaging 300 min/wk of
exercise.23 Therefore, any physical activity is probably better than
none and additional beneﬁt occurs with more physical activity. The
respondents agreed that lifestyle interventions, such as a minimal
intervention strategy for smoking cessation, should be integrated in
SET to further reduce the progression of atherosclerosis, cardio-
vascular events and even mortality. Given the frequent contacts of
physical or exercise therapist, a future role as lifestyle coaches for
these specialists is conceivable.
Currently, in the Netherlands, a nationwide network (Claudi-
catioNet) of vascular surgeons and physical therapists is being
implemented. National coverage should exist in 2015. In this
concept, physical therapists are trained in providing SET and life-
style interventions tailored to the patient’s needs. To remain in
network participation they need to comply with quality standards
such as reporting patient progress to a national database,
complying with audits and continuous medical education. After
completion of a regional network, vascular surgeons are expected
to refer only to those physical therapists, accredited by Claudica-
tioNet. Results are eagerly awaited for, but this initiativewill further
improve the quality of conservative management of PAOD in the
Netherlands.
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SET is considered an important component of themanagement of
PAOD. Conditions that are perceived as contraindications for SET,
including cardiopulmonary morbidity, are in fact additional indica-
tions for participation in an exercise programme. Limited availability
of qualiﬁed therapists and ﬁnancial barriers in health-care systems
can add to this underuse. Ideally, therapists providing SETwould also
play a role in lifestyle management of patients with PAOD.Acknowledgement
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